Serina Therapeutics annual revenue
2017
2018
2019
2020
2021
2022
2023
2024
2025
Serina Therapeutics Revenue Growth & History (SER)
Serina Therapeutics reported $130,000 in revenue for fiscal 2025, an increase of 132.14% from the previous fiscal year.
View full Serina Therapeutics company overviewSerina Therapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $130,000 | $74,000 | +132.14% |
| 2024 | 2024-12-31 | $56,000 | −$3.1M | −98.22% |
| 2023 | 2023-12-31 | $3.2M | $3.1M | +9173.53% |
| 2022 | 2022-12-31 | $34,000 | −$110,000 | −76.39% |
| 2021 | 2021-12-31 | $144,000 | −$217,000 | −60.11% |
| 2020 | 2020-12-31 | $361,000 | −$1.4M | −79.11% |
| 2019 | 2019-12-31 | $1.7M | $332,000 | +23.78% |
| 2018 | 2018-12-31 | $1.4M | −$8,000 | −0.57% |
| 2017 | 2017-12-31 | $1.4M | — | — |
Serina Therapeutics quarterly revenue
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | −$130,000 | −100.00% |
| Q1 2026 | 2026-03-31 | $0 | $0 | — |
| Q4 2025 | 2025-12-31 | $0 | $14,000 | +100.00% |
| Q3 2025 | 2025-09-30 | $0 | −$14,000 | −100.00% |
| Q2 2025 | 2025-06-30 | $130,000 | $79,000 | +154.90% |
| Q1 2025 | 2025-03-31 | $0 | −$5,000 | −100.00% |
| Q4 2024 | 2024-12-31 | −$14,000 | −$3.1M | −100.45% |
| Q3 2024 | 2024-09-30 | $14,000 | −$15,000 | −51.72% |
| Q2 2024 | 2024-06-30 | $51,000 | $44,000 | +628.57% |
| Q1 2024 | 2024-03-31 | $5,000 | −$25,000 | −83.33% |
| Q4 2023 | 2023-12-31 | $3.1M | $3.1M | +38487.50% |
| Q3 2023 | 2023-09-30 | $29,000 | $20,000 | +222.22% |
| Q2 2023 | 2023-06-30 | $7,000 | −$5,000 | −41.67% |
| Q1 2023 | 2023-03-31 | $30,000 | $25,000 | +500.00% |
| Q4 2022 | 2022-12-31 | $8,000 | −$19,000 | −70.37% |
| Q3 2022 | 2022-09-30 | $9,000 | −$15,000 | −62.50% |
| Q2 2022 | 2022-06-30 | $12,000 | −$25,000 | −67.57% |
| Q1 2022 | 2022-03-31 | $5,000 | −$51,000 | −91.07% |
| Q4 2021 | 2021-12-31 | $27,000 | −$131,000 | −82.91% |
| Q3 2021 | 2021-09-30 | $24,000 | −$45,000 | −65.22% |
| Q2 2021 | 2021-06-30 | $37,000 | −$8,000 | −17.78% |
| Q1 2021 | 2021-03-31 | $56,000 | −$33,000 | −37.08% |
| Q4 2020 | 2020-12-31 | $158,000 | −$391,000 | −71.22% |
| Q3 2020 | 2020-09-30 | $69,000 | −$342,000 | −83.21% |
| Q2 2020 | 2020-06-30 | $45,000 | −$335,000 | −88.16% |
| Q1 2020 | 2020-03-31 | $89,000 | −$299,000 | −77.06% |
| Q4 2019 | 2019-12-31 | $549,000 | $236,000 | +75.40% |
| Q3 2019 | 2019-09-30 | $411,000 | $31,000 | +8.16% |
| Q2 2019 | 2019-06-30 | $380,000 | −$84,000 | −18.10% |
| Q1 2019 | 2019-03-31 | $388,000 | $149,000 | +62.34% |
| Q4 2018 | 2018-12-31 | $313,000 | — | — |
| Q3 2018 | 2018-09-30 | $380,000 | — | — |
| Q2 2018 | 2018-06-30 | $464,000 | — | — |
| Q1 2018 | 2018-03-31 | $239,000 | — | — |
Serina Therapeutics revenue growth trends
Over the last five reported fiscal years, revenue declined from $361,000 to $130,000, a compound annual decline of 18.48%. Serina Therapeutics's latest reported quarter, Q2 2026, generated $0 in revenue, a decrease of 100.00% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Serina Therapeutics source filings ↗